Cargando…
Stable Coronary Artery Disease: Who Finally Benefits from Coronary Revascularization in the Modern Era? The ISCHEMIA and Interim ISCHEMIA-EXTEND Analysis
Coronary revascularization is one of the most studied treatment modalities in cardiology; however, there is no consensus among experts about its indications in patients with stable coronary artery disease (SCAD). Contemporary data regarding the role of revascularization in SCAD are in clear conflict...
Autores principales: | Bershtein, Leonid, Sumin, Alexey, Zbyshevskaya, Elizaveta, Gumerova, Victoria, Tsurtsumia, Darejan, Kochanov, Igor, Andreeva, Alina, Piltakian, Vartan, Sayganov, Sergey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381336/ https://www.ncbi.nlm.nih.gov/pubmed/37511870 http://dx.doi.org/10.3390/life13071497 |
Ejemplares similares
-
Revascularization and survival in multivessel coronary artery disease in ischemia
por: Maron, David J., et al.
Publicado: (2022) -
Ischemia-based Coronary Revascularization: Beyond Anatomy and Fractional Flow Reserve
por: Lim, Hong-Seok, et al.
Publicado: (2017) -
Demonstration of Ischemia in Myocardial Perfusion Scintigraphy before Coronary Revascularization Decreases Acute Coronary Syndrome-related Hospitalizations
por: Kaya, Hakki, et al.
Publicado: (2017) -
Impact of Myocardial Ischemia and Revascularization by Percutaneous Coronary Intervention on Circulating Level of Soluble ST2
por: Alkhateeb, Areej, et al.
Publicado: (2023) -
Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year—Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS)
por: Ganyukov, Vladimir, et al.
Publicado: (2020)